Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$306.88 - $380.0 $288,774 - $357,580
-941 Reduced 54.08%
799 $302,000
Q3 2023

Nov 07, 2023

BUY
$315.92 - $397.36 $549,700 - $691,406
1,740 New
1,740 $553,000
Q3 2022

Nov 07, 2022

BUY
$263.81 - $337.27 $133,224 - $170,321
505 Added 44.49%
1,640 $433,000
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $342,089 - $486,256
1,135 New
1,135 $355,000
Q2 2019

Jul 17, 2019

SELL
$279.29 - $336.89 $201,647 - $243,234
-722 Closed
0 $0
Q1 2019

Oct 17, 2019

BUY
$246.18 - $297.25 $177,741 - $214,614
722 New
722 $214,000
Q1 2018

Apr 17, 2018

SELL
$218.74 - $251.43 $600,660 - $690,426
-2,746 Closed
0 $0
Q4 2017

Jan 18, 2018

BUY
$217.88 - $244.43 $598,298 - $671,204
2,746
2,746 $598,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.54B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.